[Efficacy and safety of dexcitabine combined with HAAG regimen in the treatment of recurrent acute myeloid leukemia].
Zhonghua Yi Xue Za Zhi
; 103(13): 981-985, 2023 Apr 04.
Article
in Zh
| MEDLINE
| ID: mdl-36990713
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Receptors, Urokinase Plasminogen Activator
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Zh
Journal:
Zhonghua Yi Xue Za Zhi
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
China